NEW YORK (GenomeWeb News) – Genetic testing service firm 23andMe has done away with its subscription model following pushback from its customers and genetic genealogists.

In a note to its subscribers on Tuesday 23andMe CEO Anne Wojcicki said, "We listened to your feedback and now understand that subscriptions were not good for you and thus not good for 23andMe."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.